Roivant Sciences is focused on the development of transformative medicines and technologies, aiming to streamline and innovate across the entire spectrum of drug discovery, development, and commercialization. The company's unique operational model, driven by 'Vants'—individual agile units dedicated to specific diseases—enables deep focus and efficiency. Moreover, by working on a diverse portfolio including treatments for critical conditions such as uterine fibroids, endometriosis, diabetes, and rare pediatric diseases, Roivant is both flexible and at the forefront of addressing vast unmet medical needs.